Darius Lakdawalla, PhD, Director of Research, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, thinks that payers follow the lead of providers in oncology management.
Darius Lakdawalla, PhD, Director of Research, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, thinks that payers follow the lead of providers in oncology management. The payers do what they think patients are demanding and are the "lagging indicators" in the system. "The more we can do to generate evidence to help physicians make clinically sound decisions and help to illustrate the value of patient-centered outcomes, the better we can improve decision making," said Dr Lakdawalla.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More